nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—ERBB2—meningioma	0.883	1	CbGaD
Lapatinib—ERBB4—brainstem—meningioma	0.00146	0.0757	CbGeAlD
Lapatinib—TAP1—medulla oblongata—meningioma	0.00139	0.0723	CbGeAlD
Lapatinib—PIK3C2B—medulla oblongata—meningioma	0.00131	0.0679	CbGeAlD
Lapatinib—TAP1—spinal cord—meningioma	0.00124	0.0645	CbGeAlD
Lapatinib—PIK3C2B—spinal cord—meningioma	0.00116	0.0605	CbGeAlD
Lapatinib—ERBB4—medulla oblongata—meningioma	0.00102	0.0528	CbGeAlD
Lapatinib—TAP1—cerebellum—meningioma	0.000983	0.0511	CbGeAlD
Lapatinib—PI4KB—medulla oblongata—meningioma	0.000951	0.0494	CbGeAlD
Lapatinib—PIK3C2B—cerebellum—meningioma	0.000923	0.048	CbGeAlD
Lapatinib—ERBB4—spinal cord—meningioma	0.000905	0.0471	CbGeAlD
Lapatinib—PI4KB—spinal cord—meningioma	0.000848	0.0441	CbGeAlD
Lapatinib—TAP1—brain—meningioma	0.000799	0.0415	CbGeAlD
Lapatinib—PIK3C2B—brain—meningioma	0.00075	0.039	CbGeAlD
Lapatinib—ERBB4—cerebellum—meningioma	0.000718	0.0373	CbGeAlD
Lapatinib—ERBB2—cerebellum—meningioma	0.000718	0.0373	CbGeAlD
Lapatinib—PI4KB—cerebellum—meningioma	0.000672	0.035	CbGeAlD
Lapatinib—EGFR—cerebellum—meningioma	0.000609	0.0316	CbGeAlD
Lapatinib—ERBB2—brain—meningioma	0.000583	0.0303	CbGeAlD
Lapatinib—ERBB4—brain—meningioma	0.000583	0.0303	CbGeAlD
Lapatinib—PI4KB—brain—meningioma	0.000546	0.0284	CbGeAlD
Lapatinib—EGFR—brain—meningioma	0.000494	0.0257	CbGeAlD
Lapatinib—CYP2C8—brain—meningioma	0.000158	0.00824	CbGeAlD
Lapatinib—ABCB1—medulla oblongata—meningioma	0.000132	0.00688	CbGeAlD
Lapatinib—ABCB1—spinal cord—meningioma	0.000118	0.00613	CbGeAlD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—meningioma	0.000107	0.00109	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CST3—meningioma	0.000107	0.00109	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD34—meningioma	0.000106	0.00108	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CTSL—meningioma	0.000105	0.00108	CbGpPWpGaD
Lapatinib—TAP1—Immune System—ERBB2—meningioma	0.000105	0.00108	CbGpPWpGaD
Lapatinib—EGFR—Thromboxane A2 receptor signaling—AKT1—meningioma	0.000104	0.00107	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by SCF-KIT—AKT1—meningioma	0.000103	0.00105	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—PTEN—meningioma	0.000101	0.00104	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by SCF-KIT—AKT1—meningioma	0.000101	0.00104	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—ERBB2—meningioma	0.000101	0.00104	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—PDGFB—meningioma	0.000101	0.00104	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CTSL—meningioma	0.000101	0.00103	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—PTEN—meningioma	9.99e-05	0.00102	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—PDGFB—meningioma	9.97e-05	0.00102	CbGpPWpGaD
Lapatinib—ERBB2—Downstream signaling of activated FGFR—AKT1—meningioma	9.85e-05	0.00101	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—PDGFB—meningioma	9.72e-05	0.000994	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signaling of activated FGFR—AKT1—meningioma	9.7e-05	0.000992	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by ERBB4—AKT1—meningioma	9.69e-05	0.000991	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—ERBB2—meningioma	9.69e-05	0.000991	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—PDGFB—meningioma	9.58e-05	0.000979	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—TP53—meningioma	9.56e-05	0.000978	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by ERBB4—AKT1—meningioma	9.55e-05	0.000976	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—ERBB2—meningioma	9.54e-05	0.000975	CbGpPWpGaD
Lapatinib—EGFR—Immune System—AP1B1—meningioma	9.52e-05	0.000974	CbGpPWpGaD
Lapatinib—EGFR—LPA receptor mediated events—AKT1—meningioma	9.36e-05	0.000957	CbGpPWpGaD
Lapatinib—ABCB1—cerebellum—meningioma	9.35e-05	0.00486	CbGeAlD
Lapatinib—ERBB2—Downstream signal transduction—AKT1—meningioma	9.26e-05	0.000947	CbGpPWpGaD
Lapatinib—ERBB2—EGF/EGFR Signaling Pathway—AKT1—meningioma	9.21e-05	0.000942	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by FGFR—AKT1—meningioma	9.21e-05	0.000942	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by ERBB2—AKT1—meningioma	9.17e-05	0.000937	CbGpPWpGaD
Lapatinib—EGFR—AGE/RAGE pathway—AKT1—meningioma	9.13e-05	0.000934	CbGpPWpGaD
Lapatinib—ERBB2—DAP12 signaling—AKT1—meningioma	9.12e-05	0.000933	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signal transduction—AKT1—meningioma	9.12e-05	0.000933	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—ERBB2—meningioma	9.11e-05	0.000931	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways in Glioblastoma—TP53—meningioma	9.09e-05	0.00093	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by FGFR—AKT1—meningioma	9.07e-05	0.000928	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—ERBB2—meningioma	9.06e-05	0.000927	CbGpPWpGaD
Lapatinib—EGFR—EGF/EGFR Signaling Pathway—ERBB2—meningioma	9.06e-05	0.000927	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by ERBB2—AKT1—meningioma	9.03e-05	0.000923	CbGpPWpGaD
Lapatinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—AKT1—meningioma	9.03e-05	0.000923	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—ERBB2—meningioma	9.02e-05	0.000922	CbGpPWpGaD
Lapatinib—ERBB2—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	8.99e-05	0.000919	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 signaling—AKT1—meningioma	8.99e-05	0.000919	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—ERBB2—meningioma	8.97e-05	0.000918	CbGpPWpGaD
Lapatinib—TAP1—Immune System—PTEN—meningioma	8.97e-05	0.000917	CbGpPWpGaD
Lapatinib—EGFR—Regulation of Telomerase—AKT1—meningioma	8.92e-05	0.000912	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	8.86e-05	0.000906	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—meningioma	8.84e-05	0.000904	CbGpPWpGaD
Lapatinib—EGFR—Disease—AP1B1—meningioma	8.79e-05	0.000899	CbGpPWpGaD
Lapatinib—EGFR—Direct p53 effectors—PTEN—meningioma	8.69e-05	0.000888	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—PTEN—meningioma	8.64e-05	0.000883	CbGpPWpGaD
Lapatinib—ERBB2—DAP12 interactions—AKT1—meningioma	8.58e-05	0.000878	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by FGFR in disease—AKT1—meningioma	8.58e-05	0.000878	CbGpPWpGaD
Lapatinib—ERBB2—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	8.58e-05	0.000878	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—PDGFB—meningioma	8.58e-05	0.000877	CbGpPWpGaD
Lapatinib—TAP1—Adaptive Immune System—AKT1—meningioma	8.52e-05	0.000871	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by EGFR—AKT1—meningioma	8.51e-05	0.00087	CbGpPWpGaD
Lapatinib—ERBB4—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	8.45e-05	0.000864	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 interactions—AKT1—meningioma	8.45e-05	0.000864	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by FGFR in disease—AKT1—meningioma	8.45e-05	0.000864	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—ERBB2—meningioma	8.44e-05	0.000863	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—ERBB2—meningioma	8.44e-05	0.000863	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—ERBB2—meningioma	8.44e-05	0.000863	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by EGFR in Cancer—AKT1—meningioma	8.43e-05	0.000862	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by PDGF—AKT1—meningioma	8.39e-05	0.000858	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR—AKT1—meningioma	8.38e-05	0.000857	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—ERBB2—meningioma	8.37e-05	0.000856	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR in Cancer—AKT1—meningioma	8.3e-05	0.000849	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—ERBB2—meningioma	8.29e-05	0.000848	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by PDGF—AKT1—meningioma	8.27e-05	0.000845	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—PTEN—meningioma	8.26e-05	0.000845	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—ERBB2—meningioma	8.26e-05	0.000844	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—PTEN—meningioma	8.18e-05	0.000836	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—PTEN—meningioma	8.13e-05	0.000832	CbGpPWpGaD
Lapatinib—ERBB2—Focal Adhesion—AKT1—meningioma	8.11e-05	0.000829	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	8.08e-05	0.000826	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TSHB—meningioma	8e-05	0.000818	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—ERBB2—meningioma	7.98e-05	0.000816	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	7.94e-05	0.000812	CbGpPWpGaD
Lapatinib—ERBB2—B Cell Activation—AKT1—meningioma	7.94e-05	0.000812	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TSHB—meningioma	7.88e-05	0.000806	CbGpPWpGaD
Lapatinib—ERBB4—B Cell Activation—AKT1—meningioma	7.82e-05	0.0008	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—ERBB2—meningioma	7.81e-05	0.000799	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—PTEN—meningioma	7.77e-05	0.000794	CbGpPWpGaD
Lapatinib—EGFR—EGF/EGFR Signaling Pathway—PTEN—meningioma	7.73e-05	0.00079	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—PTEN—meningioma	7.73e-05	0.00079	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—PTEN—meningioma	7.69e-05	0.000786	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways in Glioblastoma—AKT1—meningioma	7.68e-05	0.000785	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—PTEN—meningioma	7.65e-05	0.000783	CbGpPWpGaD
Lapatinib—ERBB2—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	7.6e-05	0.000777	CbGpPWpGaD
Lapatinib—ABCB1—brain—meningioma	7.6e-05	0.00395	CbGeAlD
Lapatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—PTEN—meningioma	7.54e-05	0.000771	CbGpPWpGaD
Lapatinib—ERBB4—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	7.49e-05	0.000766	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—ERBB2—meningioma	7.48e-05	0.000765	CbGpPWpGaD
Lapatinib—EGFR—Constitutive PI3K/AKT Signaling in Cancer—AKT1—meningioma	7.39e-05	0.000756	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—PTEN—meningioma	7.2e-05	0.000736	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—PTEN—meningioma	7.2e-05	0.000736	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—PTEN—meningioma	7.2e-05	0.000736	CbGpPWpGaD
Lapatinib—EGFR—Androgen receptor signaling pathway—AKT1—meningioma	7.19e-05	0.000735	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—PTEN—meningioma	7.14e-05	0.00073	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—PTEN—meningioma	7.07e-05	0.000723	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—PTEN—meningioma	7.04e-05	0.00072	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—PTEN—meningioma	6.8e-05	0.000696	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—SMO—meningioma	6.8e-05	0.000695	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—TP53—meningioma	6.8e-05	0.000695	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	6.77e-05	0.000693	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—SMO—meningioma	6.7e-05	0.000685	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—ERBB2—meningioma	6.68e-05	0.000683	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—PTEN—meningioma	6.66e-05	0.000681	CbGpPWpGaD
Lapatinib—EGFR—PI-3K cascade—AKT1—meningioma	6.66e-05	0.000681	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—TSHB—meningioma	6.55e-05	0.000669	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—PGR—meningioma	6.52e-05	0.000667	CbGpPWpGaD
Lapatinib—EGFR—PI3K/AKT activation—AKT1—meningioma	6.5e-05	0.000665	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—HES1—meningioma	6.48e-05	0.000663	CbGpPWpGaD
Lapatinib—EGFR—GAB1 signalosome—AKT1—meningioma	6.45e-05	0.000659	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD34—meningioma	6.43e-05	0.000658	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—PGR—meningioma	6.42e-05	0.000657	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—ERBB2—meningioma	6.42e-05	0.000656	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—PTEN—meningioma	6.4e-05	0.000654	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—PTEN—meningioma	6.38e-05	0.000652	CbGpPWpGaD
Lapatinib—ERBB2—Disease—HES1—meningioma	6.37e-05	0.000651	CbGpPWpGaD
Lapatinib—EGFR—ErbB1 downstream signaling—AKT1—meningioma	6.3e-05	0.000644	CbGpPWpGaD
Lapatinib—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—meningioma	6.3e-05	0.000644	CbGpPWpGaD
Lapatinib—ERBB4—Disease—HES1—meningioma	6.27e-05	0.000641	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—PTEN—meningioma	6.18e-05	0.000632	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CTSL—meningioma	6.14e-05	0.000628	CbGpPWpGaD
Lapatinib—EGFR—Direct p53 effectors—TP53—meningioma	5.93e-05	0.000606	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—PDGFB—meningioma	5.9e-05	0.000603	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—AKT1—meningioma	5.85e-05	0.000598	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—PDGFB—meningioma	5.81e-05	0.000594	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—PTEN—meningioma	5.79e-05	0.000592	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—AKT1—meningioma	5.76e-05	0.000589	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—ERBB2—meningioma	5.75e-05	0.000588	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—PTEN—meningioma	5.7e-05	0.000583	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—TP53—meningioma	5.58e-05	0.000571	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—SMO—meningioma	5.57e-05	0.000569	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—PTEN—meningioma	5.56e-05	0.000568	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—PTEN—meningioma	5.47e-05	0.00056	CbGpPWpGaD
Lapatinib—ERBB2—Disease—PDGFB—meningioma	5.44e-05	0.000557	CbGpPWpGaD
Lapatinib—ERBB4—Disease—PDGFB—meningioma	5.36e-05	0.000548	CbGpPWpGaD
Lapatinib—EGFR—Disease—CST3—meningioma	5.23e-05	0.000535	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—ERBB2—meningioma	5.21e-05	0.000532	CbGpPWpGaD
Lapatinib—TAP1—Immune System—AKT1—meningioma	5.17e-05	0.000529	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TP53—meningioma	5.12e-05	0.000524	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—AKT1—meningioma	4.98e-05	0.000509	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—PTEN—meningioma	4.9e-05	0.000502	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—PDGFB—meningioma	4.89e-05	0.0005	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ALAD—meningioma	4.8e-05	0.000491	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—AKT1—meningioma	4.76e-05	0.000487	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—AKT1—meningioma	4.71e-05	0.000482	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—PDGFB—meningioma	4.7e-05	0.000481	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—AKT1—meningioma	4.69e-05	0.000479	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TP53—meningioma	4.62e-05	0.000473	CbGpPWpGaD
Lapatinib—ABCB1—HIF-1-alpha transcription factor network—AKT1—meningioma	4.61e-05	0.000471	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—AKT1—meningioma	4.48e-05	0.000458	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—HES1—meningioma	4.46e-05	0.000456	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—AKT1—meningioma	4.45e-05	0.000455	CbGpPWpGaD
Lapatinib—EGFR—EGF/EGFR Signaling Pathway—AKT1—meningioma	4.45e-05	0.000455	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—AKT1—meningioma	4.43e-05	0.000453	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—AKT1—meningioma	4.41e-05	0.000451	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—HES1—meningioma	4.39e-05	0.000449	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	4.35e-05	0.000444	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—AKT1—meningioma	4.33e-05	0.000442	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ALAD—meningioma	4.16e-05	0.000425	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—AKT1—meningioma	4.15e-05	0.000424	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	4.15e-05	0.000424	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—AKT1—meningioma	4.15e-05	0.000424	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—AKT1—meningioma	4.11e-05	0.00042	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—AKT1—meningioma	4.08e-05	0.000417	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—AKT1—meningioma	4.06e-05	0.000415	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	4.01e-05	0.00041	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—AKT1—meningioma	3.92e-05	0.000401	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	3.9e-05	0.000399	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—ERBB2—meningioma	3.89e-05	0.000398	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TSHB—meningioma	3.87e-05	0.000395	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—AKT1—meningioma	3.84e-05	0.000393	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—PDGFB—meningioma	3.81e-05	0.00039	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—AKT1—meningioma	3.78e-05	0.000386	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—PDGFB—meningioma	3.76e-05	0.000384	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—ERBB2—meningioma	3.71e-05	0.00038	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ALAD—meningioma	3.71e-05	0.000379	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—AKT1—meningioma	3.69e-05	0.000377	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	3.67e-05	0.000376	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ALAD—meningioma	3.62e-05	0.00037	CbGpPWpGaD
Lapatinib—ERBB4—Disease—ERBB2—meningioma	3.59e-05	0.000368	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—AKT1—meningioma	3.56e-05	0.000364	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	3.42e-05	0.00035	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—PTEN—meningioma	3.37e-05	0.000345	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—AKT1—meningioma	3.33e-05	0.000341	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—PTEN—meningioma	3.32e-05	0.000339	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SMO—meningioma	3.29e-05	0.000336	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—AKT1—meningioma	3.28e-05	0.000336	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—ERBB2—meningioma	3.28e-05	0.000335	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—AKT1—meningioma	3.2e-05	0.000327	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—AKT1—meningioma	3.15e-05	0.000323	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PGR—meningioma	3.15e-05	0.000322	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—ERBB2—meningioma	3.15e-05	0.000322	CbGpPWpGaD
Lapatinib—ERBB2—Disease—PTEN—meningioma	3.11e-05	0.000318	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—TSHB—meningioma	3.09e-05	0.000316	CbGpPWpGaD
Lapatinib—EGFR—Disease—HES1—meningioma	3.08e-05	0.000315	CbGpPWpGaD
Lapatinib—ERBB4—Disease—PTEN—meningioma	3.06e-05	0.000313	CbGpPWpGaD
Lapatinib—EGFR—Immune System—PDGFB—meningioma	2.85e-05	0.000291	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—AKT1—meningioma	2.83e-05	0.000289	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—PTEN—meningioma	2.8e-05	0.000286	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—PTEN—meningioma	2.69e-05	0.000275	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—TSHB—meningioma	2.68e-05	0.000274	CbGpPWpGaD
Lapatinib—EGFR—Disease—PDGFB—meningioma	2.63e-05	0.000269	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—ERBB2—meningioma	2.52e-05	0.000257	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—TSHB—meningioma	2.39e-05	0.000245	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—TSHB—meningioma	2.33e-05	0.000239	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	2.33e-05	0.000239	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ALAD—meningioma	2.23e-05	0.000228	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—PTEN—meningioma	2.18e-05	0.000223	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HES1—meningioma	2.15e-05	0.00022	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—PTEN—meningioma	2.15e-05	0.000219	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	1.97e-05	0.000201	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—AKT1—meningioma	1.94e-05	0.000199	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—AKT1—meningioma	1.91e-05	0.000196	CbGpPWpGaD
Lapatinib—EGFR—Immune System—ERBB2—meningioma	1.91e-05	0.000195	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PDGFB—meningioma	1.84e-05	0.000188	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—AKT1—meningioma	1.83e-05	0.000187	CbGpPWpGaD
Lapatinib—ERBB2—Disease—AKT1—meningioma	1.79e-05	0.000183	CbGpPWpGaD
Lapatinib—ERBB4—Disease—AKT1—meningioma	1.77e-05	0.000181	CbGpPWpGaD
Lapatinib—EGFR—Disease—ERBB2—meningioma	1.76e-05	0.00018	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—meningioma	1.64e-05	0.000168	CbGpPWpGaD
Lapatinib—EGFR—Immune System—PTEN—meningioma	1.63e-05	0.000167	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—AKT1—meningioma	1.61e-05	0.000165	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—AKT1—meningioma	1.55e-05	0.000158	CbGpPWpGaD
Lapatinib—EGFR—Disease—PTEN—meningioma	1.5e-05	0.000154	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TP53—meningioma	1.49e-05	0.000152	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TP53—meningioma	1.46e-05	0.00015	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—meningioma	1.46e-05	0.00015	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—TSHB—meningioma	1.44e-05	0.000147	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—AKT1—meningioma	1.26e-05	0.000128	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—AKT1—meningioma	1.24e-05	0.000126	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ERBB2—meningioma	1.24e-05	0.000126	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PTEN—meningioma	1.05e-05	0.000108	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—AKT1—meningioma	1.03e-05	0.000105	CbGpPWpGaD
Lapatinib—EGFR—Immune System—AKT1—meningioma	9.39e-06	9.6e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—AKT1—meningioma	8.67e-06	8.86e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PTEN—meningioma	8.43e-06	8.62e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PTEN—meningioma	7.3e-06	7.46e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TP53—meningioma	7.19e-06	7.35e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PTEN—meningioma	6.51e-06	6.66e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PTEN—meningioma	6.36e-06	6.5e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—AKT1—meningioma	6.07e-06	6.21e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—AKT1—meningioma	4.86e-06	4.97e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—AKT1—meningioma	4.21e-06	4.3e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PTEN—meningioma	3.92e-06	4.01e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—AKT1—meningioma	3.75e-06	3.84e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—AKT1—meningioma	3.66e-06	3.75e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—AKT1—meningioma	2.26e-06	2.31e-05	CbGpPWpGaD
